[{"address1": "5217 Winnebago Lane", "city": "Austin", "state": "TX", "zip": "78744", "country": "United States", "phone": "512 386 2900", "website": "https://www.xbiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.", "fullTimeEmployees": 82, "companyOfficers": [{"maxAge": 1, "name": "Mr. John  Simard", "age": 61, "title": "Founder, President, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 5556481, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Hu", "age": 39, "title": "Director of Finance", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 198133, "exercisedValue": 0, "unexercisedValue": 1200}, {"maxAge": 1, "name": "Dr. Sushma  Shivaswamy Ph.D.", "age": 45, "title": "Chief Scientific Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 449990, "exercisedValue": 0, "unexercisedValue": 4000}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 5, "overallRisk": 8, "governanceEpochDate": 1714521600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.36, "open": 8.38, "dayLow": 8.1, "dayHigh": 8.4601, "regularMarketPreviousClose": 8.36, "regularMarketOpen": 8.38, "regularMarketDayLow": 8.1, "regularMarketDayHigh": 8.4601, "exDividendDate": 1626307200, "beta": 1.485, "forwardPE": 63.923084, "volume": 92688, "regularMarketVolume": 92688, "averageVolume": 74917, "averageVolume10days": 46430, "averageDailyVolume10Day": 46430, "marketCap": 253101840, "fiftyTwoWeekLow": 3.51, "fiftyTwoWeekHigh": 9.96, "fiftyDayAverage": 8.325, "twoHundredDayAverage": 5.584725, "currency": "USD", "enterpriseValue": 53023820, "floatShares": 17092080, "sharesOutstanding": 30457500, "sharesShort": 709923, "sharesShortPriorMonth": 604499, "sharesShortPreviousMonthDate": 1711584000, "dateShortInterest": 1714435200, "sharesPercentSharesOut": 0.0233, "heldPercentInsiders": 0.3514, "heldPercentInstitutions": 0.12217, "shortRatio": 6.93, "shortPercentOfFloat": 0.0398, "impliedSharesOutstanding": 30457500, "bookValue": 7.19, "priceToBook": 1.155772, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -24557000, "trailingEps": -0.81, "forwardEps": 0.13, "enterpriseToEbitda": -1.483, "52WeekChange": 0.5679245, "SandP52WeekChange": 0.26137078, "lastDividendValue": 2.5, "lastDividendDate": 1626307200, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "XBIT", "underlyingSymbol": "XBIT", "shortName": "XBiotech Inc.", "longName": "XBiotech Inc.", "firstTradeDateEpochUtc": 1429104600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "fb07a30b-f4ae-35af-9fbb-83dba861caeb", "messageBoardId": "finmb_216818432", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.31, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 200023008, "totalCashPerShare": 6.569, "ebitda": -35766000, "quickRatio": 32.944, "currentRatio": 33.069, "returnOnAssets": -0.09919, "returnOnEquity": -0.10694, "freeCashflow": -16095750, "operatingCashflow": -18725000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-27"}]